Kirstin Stricker Selected Research

Osteoarthritis

9/2008	A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
7/2007	Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kirstin Stricker Research Topics

Disease

2	Malaria 01/2016 - 08/2015
2	Body Weight (Weight, Body) 08/2015 - 02/2011
2	Osteoarthritis 09/2008 - 07/2007
2	Arthritis (Polyarthritis) 08/2008 - 07/2007
1	Infertility (Sterility) 08/2015
1	Falciparum Malaria (Plasmodium falciparum Malaria) 08/2015
1	Cryopyrin-Associated Periodic Syndromes 02/2011
1	Exanthema (Rash) 02/2011
1	Heart Failure 08/2008
1	Edema (Dropsy) 08/2008
1	Hypertension (High Blood Pressure) 08/2008
1	Dysmenorrhea (Menstrual Pain) 04/2008
1	Pain (Aches) 04/2008
1	Ulcer 07/2007

Drug/Important Bio-Agent (IBA)

4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 09/2008 - 07/2007
4	lumiracoxib (prexige)IBA 09/2008 - 07/2007
4	Naproxen (Naprosyn)FDA LinkGeneric 09/2008 - 07/2007
3	Ibuprofen (Motrin)FDA LinkGeneric 09/2008 - 07/2007
2	Antimalarials (Antimalarial Agents)IBA 01/2016 - 08/2015
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 09/2008 - 07/2007
1	artemisinin (artemisinine)IBA 08/2015
1	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 08/2015
1	TabletsIBA 08/2015
1	canakinumab FDA Link 02/2011
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 02/2011
1	C-Reactive ProteinIBA 02/2011
1	Immunoglobulin G (IgG)IBA 02/2011
1	rofecoxib (Vioxx)FDA Link 09/2008
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2007

Therapy/Procedure

1	Therapeutics 08/2015